The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Mitogen-activated protein kinase pathways
Robinson, M. J., & Cobb, M. H. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80061-0 · Cited by 2,474
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,668
Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers
Schaeffer, H. J., & Weber, M. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2435 · Cited by 1,600
Liu, L., Cao, Y., Chen, C., Zhang, X., McNabola, A., Wilkie, D., Wilhelm, S., Lynch, M., & Carter, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1377 · Cited by 1,536
Phosphorylation of c-jun mediated by MAP kinases
Pulverer, B. J., Kyriakis, J. M., Avruch, J., Nikolakaki, E., & Woodgett, J. R. (1991) · Nature · doi:10.1038/353670a0 · Cited by 1,468
The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain
Marais, R., Wynne, J., & Treisman, R. (1993) · Cell · doi:10.1016/0092-8674(93)90237-k · Cited by 1,275
Coupling of the RAS-MAPK Pathway to Gene Activation by RSK2, a Growth Factor-Regulated CREB Kinase
Xing, J., Ginty, D. D., & Greenberg, M. E. (1996) · Science · doi:10.1126/science.273.5277.959 · Cited by 1,248
International Union against Cancer
(1959) · Journal of the Faculty of Radiologists · doi:10.1016/s0368-2242(59)80060-9 · Cited by 1,220
Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Abou-Alfa, G. K., Schwartz, L., Ricci, S., Amadori, D., Santoro, A., Figer, A., De Greve, J., Douillard, J.-Y., Lathia, C., Schwartz, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.3441 · Cited by 1,195
Targeting the mitogen-activated protein kinase cascade to treat cancer
Sebolt-Leopold, J. S., & Herrera, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1503 · Cited by 1,108
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.
Saito, I., Miyamura, T., Ohbayashi, A., Harada, H., Katayama, T., Kikuchi, S., Watanabe, Y., Koi, S., Onji, M., & Ohta, Y. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6547 · Cited by 1,089
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions
Pearson, G. (2001) · Endocrine Reviews · doi:10.1210/er.22.2.153 · Cited by 1,060
Xiong, Y., Connolly, T., Futcher, B., & Beach, D. (1991) · Cell · doi:10.1016/0092-8674(91)90100-d · Cited by 685
Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
and members of the Southeast Sweden Breast Cancer Group, Pérez-Tenorio, G., & Stål, O. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600126 · Cited by 394
Ito, Y., Sasaki, Y., Horimoto, M., Wada, S., Tanaka, Y., Kasahara, A., Ueki, T., Hirano, T., Yamamoto, H., Fujimoto, J., et al. (1998) · Hepatology · doi:10.1002/hep.510270409 · Cited by 334
Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma.
Nishida, N., Fukuda, Y., Komeda, T., Kita, R., Sando, T., Furukawa, M., Amenomori, M., Shibagaki, I., Nakao, K., & Ikenaga, M. (1994) · PubMed · Cited by 330
Development of anticancer drugs targeting the MAP kinase pathway
Sebolt-Leopold, J. S. (2000) · Oncogene · doi:10.1038/sj.onc.1204083 · Cited by 320
Signal transduction within the nucleus by mitogen-activated protein kinase.
Seth, A., Gonzalez, F. A., Gupta, S., Raden, D. L., & Davis, R. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35834-4 · Cited by 315
O'Farrell, A.-M., Foran, J. M., Fiedler, W., Serve, H. L., Paquette, R. L., Cooper, M. A., Yuen, H. A., Louie, S. G., Kim, H., Nicholas, S., et al. (2003) · PubMed · Cited by 310
伊藤, 善. (1998) · doi:10.11501/3155565 · Cited by 300
Chen, R. H., Abate, C., & Blenis, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10952 · Cited by 298
Huynh, H., Nguyen, T. T. T., Chow, K.-H. K.-P., Tan, P. H., Soo, K. C., & Tran, E. (2003) · BMC Gastroenterology · doi:10.1186/1471-230x-3-19 · Cited by 289
Sef Is a Spatial Regulator for Ras/MAP Kinase Signaling
Torii, S., Kusakabe, M., Yamamoto, T., Maekawa, M., & Nishida, E. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.05.019 · Cited by 278
Amplification and Overexpression of Cyclin D1 in Human Hepatocellular Carcinoma
Zhang, Y. J., Jiang, W., Chen, C. J., Lee, C. S., Kahn, S. M., Santella, R. M., & Weinstein, I. B. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2350 · Cited by 241
Prognostic Significance of Activated Akt Expression in Pancreatic Ductal Adenocarcinoma
Yamamoto, S., Tomita, Y., Hoshida, Y., Morooka, T., Nagano, H., Dono, K., Umeshita, K., Sakon, M., Ishikawa, O., Ohigashi, H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-02-1441 · Cited by 241
Nakanishi, K., Sakamoto, M., Yamasaki, S., Todo, S., & Hirohashi, S. (2005) · Cancer · doi:10.1002/cncr.20774 · Cited by 222
Cyclin D1 Regulates Cellular Migration through the Inhibition of Thrombospondin 1 and ROCK Signaling
Li, Z., Wang, C., Jiao, X., Lu, Y., Fu, M., Quong, A. A., Dye, C., Yang, J., Dai, M., Ju, X., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02124-05 · Cited by 177
Tsutsumi, T., Suzuki, T., Moriya, K., Shintani, Y., Fujie, H., Miyoshi, H., Matsuura, Y., Koike, K., & Miyamura, T. (2003) · Hepatology · doi:10.1002/hep.1840380408 · Cited by 115
Zhao, L., Wang, L., Ren, H., Cao, J., LI, L., KE, J., & QI, Z. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.12.024 · Cited by 114
Milde‐Langosch, K., Bamberger, A., Rieck, G., Grund, D., Hemminger, G., Müller, V., & Löning, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602655 · Cited by 110
Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma1
Wiesenauer, C. A., Yip-Schneider, M., Wang, Y., & Schmidt, C. M. (2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2003.10.004 · Cited by 101
Cyclin D1 overexpression in hepatocellular carcinoma
Joo, M., Kang, Y. K., Kim, M., Lee, H., & Jang, J. (2001) · Liver International · doi:10.1034/j.1600-0676.2001.021002089.x · Cited by 100
Schmitz, K. J., Otterbach, F., Callies, R., Levkau, B., Hölscher, M., Hoffmann, O. I., Grabellus, F., Kimmig, R., Schmid, K. W., & Baba, H. A. (2003) · Modern Pathology · doi:10.1038/modpathol.3800002 · Cited by 98
Self-citationSato, Y., Kato, J., Takimoto, R., Takada, K., Kawano, Y., Miyanishi, K., Kobune, M., Sato, Y., Takayama, T., Matunaga, T., et al. (2006) · Gut · doi:10.1136/gut.2005.070417 · Cited by 88
Handra‐Luca, A., Bilal, H., Bertrand, J.-C., & Fouret, P. J. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63455-4 · Cited by 83
New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system
Berasain, C., Castillo, J., Prìeto, J., & Avila, M. A. (2007) · Liver International · doi:10.1111/j.1478-3231.2006.01424.x · Cited by 80
Tsuboi, Y., Ichida, T., Sugitani, S., Genda, T., Inayoshi, J., Takamura, M., Matsuda, Y., Nomoto, M., & Aoyagi, Y. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0940.x · Cited by 77
Schmitz, K. J., Wohlschlaeger, J., Alakus, H., Bohr, J., Stauder, M., Worm, K., Winde, G., Schmid, K. W., & Baba, H. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-006-0342-y · Cited by 58
Self-citationGivant-Horwitz, V., Davidson, B., Lazarovici, P., SCHAEFER, E. M., Nesland, J. M., Trope, C. G., & Reich, R. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00434-7 · Cited by 58
Cited by
Molecular targeted therapies in hepatocellular carcinoma†
Llovet, J. M., & Bruix, J. (2008) · Hepatology · doi:10.1002/hep.22506 · Cited by 1,004
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
Whittaker, S., Marais, R., & Zhu, A. X. (2010) · Oncogene · doi:10.1038/onc.2010.236 · Cited by 825
Cheng, A.-L., Kang, Y.-K., Lin, D.-Y., Park, J.-W., Kudo, M., Qin, S., Chung, H.-C., Song, X., Xu, J., Poggi, G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.8372 · Cited by 777
Molecular mechanisms of hepatocellular carcinoma
Aravalli, R. N., Steer, C. J., & Cressman, E. N. K. (2008) · Hepatology · doi:10.1002/hep.22580 · Cited by 625
Asati, V., Mahapatra, D. K., & Bharti, S. K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.012 · Cited by 612
Metadata
- Authors
- Schmitz, K. J., Wohlschlaeger, J., Lang, H., Sotiropoulos, G. C., Malago, M., Steveling, K., Reis, H., Cicinnati, V. R., Schmid, K. W., & Baba, H. A.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 48
- Issue
- 1
- Pages
- 83-90
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2058388078
- Cited by
- 309
- References
- 43
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.